A sweeping US law pertaining to pharmaceuticals tracking and accounting, which will require stricter tracking of drugs’ provenance from production to distribution, might be a perfect fit as a blockchain application, say health care analysts. This law, the “DSCSA”, will come fully into effect in a few years, and has sent the pharma industry scrambling for solutions for its implementation. For Further Information Click on Below Button